CNI-1493 inhibits Aβ production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease

Alzheimer's disease (AD) is characterized by neuronal atrophy caused by soluble amyloid β protein (Aβ) peptide “oligomers” and a microglial-mediated inflammatory response elicited by extensive amyloid deposition in the brain. We show that CNI-1493, a tetravalent guanylhydrazone with established...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacher, Michael, Dodel, Richard, Aljabari, Bayan, Keyvani, Kathy, Marambaud, Philippe, Kayed, Rakez, Glabe, Charles, Goertz, Nicole, Hoppmann, Anne, Sachser, Norbert, Klotsche, Jens, Schnell, Susanne, Lewejohann, Lars, Al-Abed, Yousef
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2008
Materias:
Brief Definitive Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442637/
https://www.ncbi.nlm.nih.gov/pubmed/18573905
http://dx.doi.org/10.1084/jem.20060467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442637/
https://www.ncbi.nlm.nih.gov/pubmed/18573905
http://dx.doi.org/10.1084/jem.20060467

Ejemplares similares